These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24317684)

  • 61. Dysregulated gene expression predicts tumor aggressiveness in African-American prostate cancer patients.
    Ali HEA; Lung PY; Sholl AB; Gad SA; Bustamante JJ; Ali HI; Rhim JS; Deep G; Zhang J; Abd Elmageed ZY
    Sci Rep; 2018 Nov; 8(1):16335. PubMed ID: 30397274
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased expression of tumor protein D54 is associated with clinical progression and poor prognosis in patients with prostate cancer.
    Ren L; Chen J; Zhang X
    Oncol Lett; 2017 Dec; 14(6):7739-7744. PubMed ID: 29250174
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prostate Cancer Risk and DNA Methylation Signatures in Aging Rats following Developmental BPA Exposure: A Dose-Response Analysis.
    Prins GS; Ye SH; Birch L; Zhang X; Cheong A; Lin H; Calderon-Gierszal E; Groen J; Hu WY; Ho SM; van Breemen RB
    Environ Health Perspect; 2017 Jul; 125(7):077007. PubMed ID: 28728135
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.
    Zhao Z; Liu H; Hou J; Li T; Du X; Zhao X; Xu W; Xu W; Chang J
    Oncol Res; 2017 May; 25(5):773-779. PubMed ID: 27983909
    [TBL] [Abstract][Full Text] [Related]  

  • 65. DNA methylome changes by estradiol benzoate and bisphenol A links early-life environmental exposures to prostate cancer risk.
    Cheong A; Zhang X; Cheung YY; Tang WY; Chen J; Ye SH; Medvedovic M; Leung YK; Prins GS; Ho SM
    Epigenetics; 2016 Sep; 11(9):674-689. PubMed ID: 27415467
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma.
    Wang Y; Chen CL; Pan QZ; Wu YY; Zhao JJ; Jiang SS; Chao J; Zhang XF; Zhang HX; Zhou ZQ; Tang Y; Huang XQ; Zhang JH; Xia JC
    Oncotarget; 2016 Feb; 7(5):6323-34. PubMed ID: 26575170
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TPD52 expression increases neutral lipid storage within cultured cells.
    Kamili A; Roslan N; Frost S; Cantrill LC; Wang D; Della-Franca A; Bright RK; Groblewski GE; Straub BK; Hoy AJ; Chen Y; Byrne JA
    J Cell Sci; 2015 Sep; 128(17):3223-38. PubMed ID: 26183179
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mapping and Identification of the Urine Proteome of Prostate Cancer Patients by 2D PAGE/MS.
    Kiprijanovska S; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M; Davalieva K
    Int J Proteomics; 2014; 2014():594761. PubMed ID: 25215235
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.
    Ummanni R; Teller S; Junker H; Zimmermann U; Venz S; Scharf C; Giebel J; Walther R
    FEBS J; 2008 Nov; 275(22):5703-13. PubMed ID: 18959755
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer.
    Byrne JA; Balleine RL; Schoenberg Fejzo M; Mercieca J; Chiew YE; Livnat Y; St Heaps L; Peters GB; Byth K; Karlan BY; Slamon DJ; Harnett P; Defazio A
    Int J Cancer; 2005 Dec; 117(6):1049-54. PubMed ID: 15986428
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52.
    Shehata M; Bièche I; Boutros R; Weidenhofer J; Fanayan S; Spalding L; Zeps N; Byth K; Bright RK; Lidereau R; Byrne JA
    Clin Cancer Res; 2008 Aug; 14(16):5050-60. PubMed ID: 18698023
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
    Byrne JA; Frost S; Chen Y; Bright RK
    Tumour Biol; 2014 Aug; 35(8):7369-82. PubMed ID: 24798974
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Patterns of TPD52 overexpression in multiple human solid tumor types analyzed by quantitative PCR.
    Tennstedt P; Bölch C; Strobel G; Minner S; Burkhardt L; Grob T; Masser S; Sauter G; Schlomm T; Simon R
    Int J Oncol; 2014 Feb; 44(2):609-15. PubMed ID: 24317684
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.